Musso Alan A has filed 8 insider transactions across 2 companies since October 2023.
Most recent transaction: a grant/award of 170000 shares of Fulcrum Therapeutics, Inc. ($FULC) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Fulcrum Therapeutics, Inc. | $FULC | Musso Alan A | Chief Financial Officer | A | Stock Option (right to buy) | 170000 | $0.00 | 170,000.0000 | 62,597,000 | 9999.99% | 0.27% |
| July 23, 2025 | Rein Therapeutics, Inc. | $RNTX | Musso Alan A | Not found | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 17,938,899 | 9999.99% | 0.10% |
| Jan. 24, 2025 | Fulcrum Therapeutics, Inc. | $FULC | Musso Alan A | Chief Financial Officer | A | Stock Option (right to buy) | 285000 | $0.00 | 285,000.0000 | 61,984 | 9999.99% | 100.00% |
| Dec. 2, 2024 | Rein Therapeutics, Inc. | $RNTX | Musso Alan A | Not found | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 21,663,089 | 9999.99% | 0.16% |
| Aug. 20, 2024 | Rein Therapeutics, Inc. | $RNTX | Musso Alan A | Not found | A | Stock Option (right to buy) | 2725 | $0.00 | 2,725.0000 | 4,598,715 | 9999.99% | 0.06% |
| Jan. 26, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Musso Alan A | Chief Financial Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 61,310 | 9999.99% | 100.00% |
| Jan. 17, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Musso Alan A | Chief Financial Officer | A | Stock Option (right to buy) | 61822 | $0.00 | 61,822.0000 | 61,310 | 9999.99% | 100.00% |
| Oct. 31, 2023 | Rein Therapeutics, Inc. | $RNTX | Musso Alan A | Director | A | Stock Option (right to buy) | 5450 | $0.00 | 5,450.0000 | 0 | 9999.99% | 0.00% |